The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

NCT02020434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjects With Varying Degrees of Renal Insufficiency and
Subjects With Normal Renal Function

Interventions

DRUG: RPX7009 and RPX2014

Sponsor

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)